Evidence map›Paper›PMID 42751666›Full record

ArticleBioinformatics advances2026

MiLaSol: modeling protein solubility by mixing up multiple protein language models.

Weiwei Lou, Mert Erden, Lenore Cowen

Abstract read
In one paragraph

Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Weiwei LouDepartment of Computer Science, Tufts University, Medford, MA 02155, United States.
Mert ErdenDepartment of Computer Science, Tufts University, Medford, MA 02155, United States.
Lenore CowenDepartment of Computer Science, Tufts University, Medford, MA 02155, United States.ORCID https://orcid.org/0000-0001-6698-6413

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Protein solubility is a critical property that significantly impacts therapeutic efficacy and protein reengineering applications. Recent advances in machine learning and deep learning techniques provide unprecedented opportunities to develop predictive models for solubility, enabling more efficient protein design and optimization. This work is motivated by the potential of leveraging deep learning to address the solubility prediction challenge and to accelerate protein engineering workflows. Results: Leveraging and combining multiple protein language model representations, our MiLaSol model attains 81% accuracy, outperforming prior methods, with the highest Matthews Correlation Coefficient (MCC) score of 0.63 demonstrating balanced performance across both soluble and insoluble proteins. Through simulated annealing optimization coupled with the Raygun model, we also present a computational method to reengineer insoluble protein variants into soluble forms, with predictions confirmed by multiple independent solubility prediction methods. Our results demonstrate the effectiveness of combining machine learning-based solubility prediction with generative optimization for protein engineering. Availability and implementation: MiLaSol is available at https://github.com/weiweiloutufts/milasolAn archived version of the code at the time of submission can be found at https://doi.org/10.5281/zenodo.21495202.

Identifiers

PMID42751666
PMCPMC13581264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.